Wave Pod
Discover
Library
Get Wave AI
Sign In
NEJM February 2026 Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer - This Week In Medicine | Wave AI Podcast Notes
← This Week In Medicine
This Week In Medicine
NEJM February 2026 Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer
February 26, 2026
·
00:18:58
Send to my inbox
Sign in to save
Share
Health & Fitness
Loading summary
Sign in to transcribe
